Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
Hari Ram Choudhary, Debaprasad Parai, Girish Chandra Dash, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 1045-1048
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort
Annalan M D Navaratnam, Madhumita Shrotri, Vincent Nguyen, et al.
International Journal of Infectious Diseases (2022) Vol. 123, pp. 104-111
Open Access | Times Cited: 40
Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
Hari Ram Choudhary, Debaprasad Parai, Girish Chandra Dash, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 41
Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors
Neâl Alexander, Christopher Dye, Michael P. Busch, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0308319-e0308319
Open Access
High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals
Kim Blom, Ilias Galanis, Philip Bacchus, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 1, pp. e0003300-e0003300
Open Access
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
Marzia Cavalli, Giulia Campoli, Anna Anselmo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 seroprevalence and associated risk factors in adult outpatients from Western Romania, January to March 2023: a seroepidemiological assessment after three years of COVID-19 pandemic
Tudor Rareș Olariu, Sorin Ursoniu, Alina Cristiana Craciun, et al.
Infectious Diseases (2025), pp. 1-11
Open Access
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
Alexandra Rak, N. Gorbunov, В. А. Костевич, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 230-230
Open Access | Times Cited: 11
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 10
Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population
Michael Asamoah-Boaheng, David A. Goldfarb, Vilte Barakauskas, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 17
IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi
Muhammad Nazmul Hasan, Bushra Moiz, Shama Qaiser, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0271259-e0271259
Open Access | Times Cited: 15
Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
Yu‐Lei Chen, Jin-Jin Lin, Huan Ma, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10904-10904
Open Access | Times Cited: 12
Cumulative incidence of SARS‐CoV‐2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Jorge Camacho, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 12
No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)
Kendall Kling, Patrick Janulis, Alexis R. Demonbreun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 7
The severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) omicron sub-variants in Bangladesh cause mild COVID-19 and associate with similar antibody responses irrespective of natural infection or vaccination history
Simon D. Lytton, Asish Kumar Ghosh, Md. Rakibul Hassan Bulbul, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31011-e31011
Open Access | Times Cited: 2
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India
Matt D. T. Hitchings, Eshan U. Patel, Rifa Khan, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 9, pp. 1552-1561
Open Access | Times Cited: 6
High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa
Shobna Sawry, Jean Le Roux, Nicole Wolter, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 241-249
Open Access | Times Cited: 10
Spike- and nucleocapsid-based gold colloid assay toward the development of an adhesive bandage for rapid SARS-CoV-2 immune response detection and screening
Imen Boumar, Muhammedin Deliorman, Pavithra Sukumar, et al.
Microsystems & Nanoengineering (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response
Aidan M. Nikiforuk, Brynn McMillan, Sofia Bartlett, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 9
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies
Ida Jarlhelt, Laura Pérez‐Alós, Rafael Bayarri‐Olmos, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 4
JN.1: The new COVID-19 variant of concern?
Ruby Dhar, Hiya Aidasani, Om Saswat Sahoo, et al.
Asian Journal of Medical Sciences (2024) Vol. 15, Iss. 2, pp. 251-253
Open Access | Times Cited: 1
A handheld luminometer with sub-attomole limit of detection for distributed applications in global health
Paul Lebel, Susanna K. Elledge, Diane M. Wiener, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 2, pp. e0002766-e0002766
Open Access | Times Cited: 1
Antibody response three months after SARS‐CoV‐2 infection
Efdal OKTAY GÜLTEKİN, Onur GÜLTEKİN, Arzu Coşkun, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4712-4718
Open Access | Times Cited: 7
Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors
Jasmina Grujić, Nevenka Bujandrić, Zorana Budakov-Obradović, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 42-42
Open Access | Times Cited: 9
Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia
Nathalie V. Fernández Villalobos, Patrick Marsall, Johanna Carolina Torres Páez, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top